Cannabix Technologies Reaches Development Milestone with Marijuana Breathalyzer Devices - Provides New Pictures
November 18 2019 - 5:40AM
InvestorsHub NewsWire
501-3292
Production Way, Burnaby, B.C., V5A 4R4
Phone:
(604) 551-7831 Fax:
604-676-2767
info@cannabixtechnologies.com
cannabixtechnologies.com
Cannabix
Technologies
Reaches
Development Milestone with
Marijuana Breathalyzer
Devices
–
Provides
New
Pictures
Cannabix
is developing
Marijuana
Breathalyzer
devices to
give law enforcement and employers
a
tool to
enhance
public safety
Vancouver, British
Columbia -- November
18,
2019 -- InvestorsHub
NewsWire -- Cannabix
Technologies Inc.
(CSE: BLO) (OTC PINK: BLOZF) (the "Company or Cannabix")
developer of
marijuana breathalyzer devices for law enforcement and the
workplace, reports that engineers
have completed assembly
of a handheld portable version of
the (UBC)
THC
Breath Analyzer and are preparing the
device to build upon promising human tests conducted earlier this
year in Kelowna BC. Over the last
several weeks, Company engineers have reduced the size of several
components inside the THCBA for a compact handheld
device. Cannabix
has
been conducting
extensive
lab
testing with the new
device. The THC Breath
Analyzer ("THCBA")
incorporates sensitive microfluidic sensor technology for the
detection of ?9-tetrahydrocannabinol ("THC") from breath.
Furthermore,
several
software upgrades are being completed to
use
cloud-based
machine
learning (ML)
techniques
to process data more
quickly. Initial ML analysis
will be performed by experts at UBC. Cannabix
is
commissioning
several
additional
units in the short
term and
expects
that these
devices
will be available
for broader
multisite
testing
this
winter.
The
Company has made
the
first pictures of the
newly built THCBA
available
on its
website at cannabixtechnologies.com
Dr.
Mina Hoorfar
stated,
"We have been
working hard in collaboration with Cannabix
to
optimize the device and its components. Our mutual goal
continues to be developing an affordable, portable, fast and
accurate device for use with a range of potential
users."
Rav
Mlait, CEO, stated, "Our team has been working intensely on our
devices for the law enforcement and workplace markets. Several
additional police, private and government related agencies have
been in touch with Cannabix this fall, showing
interest in piloting our devices, as marijuana use for recreational
and medical purposes is expanding across various jurisdictions in
the United States and we have
surpassed one year of recreational use across Canada.
Furthermore, we are
seeing police and others becoming more open to new technologies
related to cannabis impairment detection. We are very excited for
the additional prospects for the THCBA because of its single stage,
direct breath capability, compact portable design and ability to
provide results quickly."
The
Company reports that it has
improved several components within
its
FAIMS (field asymmetric waveform ion mobility spectrometry)
THC
detection
device.
More
recently, engineers
have enhanced
sample flow conditions
within the unit, worked intensely on ion
optics
and are testing a new multi-plate
detector unit. The Company is also
pleased to report that it has
been testing with
both
direct breath and breath collection methods using the FAIMS
system.
About
Cannabix
Technologies
Inc.
Cannabix
Technologies Inc.
is a leader in marijuana breathalyzer development for law
enforcement and the workplace.
Cannabix
has
established breath testing technologies in the pursuit of bringing
durable, portable tools to market to enhance detection of marijuana
impaired driving offences on roads at a time when marijuana is
becoming legal in many global jurisdictions. Cannabix
is
working to develop drug-testing devices that will detect THC- the
psychoactive component of marijuana that causes intoxication- using
breath samples. In particular, Cannabix
is
focused on developing breath testing devices for detection of
recent use of THC, in contrast to urine testing for THC metabolite
that requires an invasive collection and reflects
usage,
days or
even weeks earlier. The devices will also be useful for other
practical applications such as testing employees in the workplace
where impairment
by THC
can be hazardous.
We seek
Safe Harbor.
On
behalf of the Board of Directors
"Rav
Mlait"
CEO
Cannabix
Technologies
Inc.
For further information, contact the Company at
info@cannabixtechnologies.com
The
CSE has not reviewed and does not accept responsibility for the
adequacy or accuracy of this release.
Cautionary
Statement Regarding Forward-Looking Statements
This
press release contains forward-looking information that involves
various risks and uncertainties regarding future events. Such
forward-looking information can include without limitation
statements based on current expectations involving a number of
risks and uncertainties and are not guarantees of future
performance of the Company, such as final development of a
commercial or prototype product(s), successful trial or pilot of
company technologies, no assurance that commercial sales of any
kind actually materialize; no assurance the Company will have
sufficient funds to complete product development. There are
numerous risks and uncertainties that could cause actual results
and the Company's plans and objectives to differ materially from
those expressed in the forward-looking information, including:
(i)
adverse market conditions; (ii) risks regarding protection of
proprietary technology; (iii) the ability of the Company to
complete financings; (iv) the ability of the Company to develop and
market its future product; and (v) risks regarding government
regulation, managing and maintaining growth, the effect of adverse
publicity, litigation, competition and other factors which may be
identified from time to time in the Company's public announcements
and filings. There is no assurance that the marijuana breathalyzer
business will provide any benefit to the Company, and no assurance
that any proposed new products will be built or proceed. There is
no assurance that existing "patent pending" technologies licensed
by the Company will receive patent status by regulatory
authorities. The Company is not currently selling commercial
breathalyzers. Actual results and future events could differ
materially from those anticipated in such information. These and
all subsequent written and oral forward-looking information are
based on estimates and opinions of management on the dates they are
made and are expressly qualified in their entirety by this notice.
Except as required by law, the Company does not intend to update
these forward-looking statements.
Cannabix Technologies (PK) (USOTC:BLOZF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cannabix Technologies (PK) (USOTC:BLOZF)
Historical Stock Chart
From Sep 2023 to Sep 2024